A phase II study of intensive-dose topotecan, ifosfamide/mesna and etoposide (TIME) followed by autologous stem cell rescue in metastatic breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Etoposide; Ifosfamide; Topotecan
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 11 Dec 2012 Biomarkers information updated
- 30 Sep 2005 New trial record.